March 25, 2021 Press Releases

ICYMI: New York Times Opinion: Taxpayers Fund Research and Drug Companies Make a Fortune

WASHINGTON, D.C. — The New York Times today published an op-ed by David Mitchell, cancer patient and founder of Patients For Affordable Drugs, breaking down how the COVID-19 vaccine story makes it clearer than ever why Americans need our government to negotiate prices for all prescription drugs – including vaccines. Mitchell’s piece is in response to experts’ predictions that we will continue to need COVID-19 vaccines for years to come and vaccine makers’ warnings that they will raise vaccine prices in the future.

Click here to read the full article.

###

JOIN US

Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.